Bent Frandsen

Chief Executive Officer at EXPRES2ION BIOTECH HOLDING AB

Health Technology

Consumer Services

Profile

Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.

Bent Frandsen active positions

Companies	Position	Start
EXPRES2ION BIOTECH HOLDING AB	Chief Executive Officer	2019-12-19
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Chief Executive Officer	-

All active positions of Bent Frandsen

Former positions of Bent Frandsen

Companies	Position	End
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Corporate Officer/Principal	-
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Director/Board Member	-

See the detail of Bent Frandsen's experience

Training of Bent Frandsen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bent Frandsen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Copenhagen Business School Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Health Technology
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Health Technology
Expres2ion Biotech Holding AB Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer	Health Technology
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Health Technology